Metropolis Healthcare Ltd (METP)

Currency in INR
2,008.40
+13.80(+0.69%)
Closed·
METP Scorecard
Full Analysis
Impressive gross profit margins
METP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,978.302,030.00
52 wk Range
1,315.002,318.30
Key Statistics
Bid/Ask
2,005.00 / 2,008.40
Prev. Close
1,994.6
Open
2,024.5
Day's Range
1,978.3-2,030
52 wk Range
1,315-2,318.3
Volume
55.61K
Average Volume (3m)
153.69K
1-Year Change
-2.41%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
METP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,949.58
Downside
-2.93%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Metropolis Healthcare Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Metropolis Healthcare Ltd Company Profile

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, youth, and corporates. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, a mobile app, a website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.

Employees
4823
Market
India

Compare METP to Peers and Sector

Metrics to compare
METP
Peers
Sector
Relationship
P/E Ratio
68.4x66.5x−0.5x
PEG Ratio
6.450.980.00
Price/Book
7.8x3.1x2.6x
Price / LTM Sales
7.4x4.1x3.3x
Upside (Analyst Target)
−0.4%10.4%43.4%
Fair Value Upside
Unlock−7.7%7.1%Unlock

Analyst Ratings

13 Buy
1 Hold
5 Sell
Ratings:
19 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1,949.58
(-2.93% Downside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
8.75 / 8.17
Revenue / Forecast
3.86B / 3.82B
EPS Revisions
Last 90 days

METP Income Statement

People Also Watch

5,815.50
KAYN
-4.49%
2,552.60
ANGO
-3.38%
821.85
LAUL
-1.96%
4,170.10
AVEU
-2.19%
14,462.00
SLIN
-2.91%

FAQ

What Stock Exchange Does Metropolis Healthcare Trade On?

Metropolis Healthcare is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Metropolis Healthcare?

The stock symbol for Metropolis Healthcare is "METP."

What Is the Metropolis Healthcare Market Cap?

As of today, Metropolis Healthcare market cap is 104.05B.

What Is Metropolis Healthcare's Earnings Per Share (TTM)?

The Metropolis Healthcare EPS (TTM) is 29.59.

When Is the Next Metropolis Healthcare Earnings Date?

Metropolis Healthcare will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is METP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Metropolis Healthcare Stock Split?

Metropolis Healthcare has split 0 times.

How Many Employees Does Metropolis Healthcare Have?

Metropolis Healthcare has 4823 employees.

What is the current trading status of Metropolis Healthcare (METP)?

As of 10 Aug 2025, Metropolis Healthcare (METP) is trading at a price of 2,008.40, with a previous close of 1,994.60. The stock has fluctuated within a day range of 1,978.30 to 2,030.00, while its 52-week range spans from 1,315.00 to 2,318.30.

What Is Metropolis Healthcare (METP) Price Target According to Analysts?

The average 12-month price target for Metropolis Healthcare is INR1949.57895, with a high estimate of INR2375 and a low estimate of INR1400. 13 analysts recommend buying the stock, while 5 suggest selling, leading to an overall rating of Buy. The stock has an -2.93% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.